• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

No benefit of sodium bicarbonate or acetylcysteine for prevention of complications after angiography: The PRESERVE trial

byIyas DaghlasandDayton McMillan
February 15, 2018
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Nephrology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Amongst patients undergoing angiography, neither sodium bicarbonate nor acetylcysteine were effective in preventing a composite outcome of death, need for dialysis, or persistent kidney injury.

2. The treatments were also ineffective in reducing risk of contrast-associated acute kidney injury.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Contrast used in angiography is associated with numerous health risks including death, acute kidney injury, and chronic kidney injury. Intravenous sodium bicarbonate and oral acetylcysteine have been used based on theoretical mitigation of this risk, but their efficacy is unclear. The PRESERVE (Prevention of Serious Adverse Events Following Angiography) trial sought to investigate the efficacy of these treatment strategies in reducing the risk for a primary composite outcome of death, need for dialysis, or persistent kidney injury. No benefit was observed with used of intravenous bicarbonate compared to normal saline, and there was no benefit of oral acetylcysteine compared to placebo in rates of the primary outcome. Risk for acute kidney injury was not affected by the treatments. This trial provides robust evidence for lack of efficacy of sodium bicarbonate or acetylcysteine in prevention of angiography contrast-related complications amongst patients with kidney disease.

Strengths of the study include its randomized design and robust sample size. The use of a selected population with many patients from Veterans Affairs hospitals with chronic kidney disease undergoing angiography limits generalizability.

Click to read the study, published in NEJM

RELATED REPORTS

#VisualAbstract: Empagliflozin Has Cardiorenal Benefits for Chronic Kindey Disease

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

Nivolumab does not improve survival in patients with advanced renal cell carcinoma with progression after immune checkpoint inhibitors

Relevant Reading: Economic burden of contrast-induced nephropathy: implications for prevention strategies

In-Depth [randomized controlled trial]: This was a multinational randomized controlled trial conducted from 2013 to 2017 that enrolled a total of 4993 patients for primary analysis. Patients were eligible for inclusion if they were scheduled to undergo angiography and had an estimated glomerular filtration rate of 15 to 44.9, or 45 to 59.9 and were diabetic. Exclusion criteria included emergency angiography or variable changes in blood creatinine within three days of the procedure. Patients were randomized in a 2×2 design, with 1.26% sodium bicarbonate (n = 2511) compared to 0.9% sodium chloride (n = 2482), and oral acetylcysteine (n = 2495) compared to placebo (n = 2498). The primary outcome was a composite of need for dialysis, persistent kidney injury, or death within 90 days. A key secondary end point was rate of contrast-induced kidney injury. Notably, 93.6% of patients were men and 80.9% had diabetes mellitus.

There was no difference in rate of the composite endpoint in the sodium bicarbonate group (4.4%) relative to the sodium chloride group (4.7%) (odds ratio [OR], 0.93; 95% confidence interval [CI], 0.72 to 1.22; p = 0.62). There was no difference in the primary outcome in the acetylcysteine group (4.6%) relative to the placebo group (4.5%) (OR, 1.02; 95%CI, 0.78 to 1.33; p = 0.88). There was no benefit of treatment with both bicarbonate and acetylcysteine (p for interaction = 0.33). There was no difference in risk of contrast-induced acute kidney injury in the treatment groups relative to the comparator groups (p = 0.46).

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute kidney injurypercutaneous coronary interventionrenal
Previous Post

Nusinersen improves motor function in children with later-onset spinal muscular atrophy: The CHERISH trial

Next Post

2 Minute Medicine Rewind February 19, 2018

RelatedReports

#VisualAbstract: Empagliflozin Has Cardiorenal Benefits for Chronic Kindey Disease
StudyGraphics

#VisualAbstract: Empagliflozin Has Cardiorenal Benefits for Chronic Kindey Disease

March 6, 2025
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

February 11, 2025
Radiographic surrogates may predict tumor-specific survival in renal carcinoma
Chronic Disease

Nivolumab does not improve survival in patients with advanced renal cell carcinoma with progression after immune checkpoint inhibitors

October 30, 2024
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Optical coherence tomography-guided angioplasty reduces adverse events compared to angiography guidance

October 1, 2024
Next Post

2 Minute Medicine Rewind February 19, 2018

Maternal vaccination during pregnancy not associated with infant hospitalization, mortality

Maternal vaccination during pregnancy not associated with infant hospitalization, mortality

Quality improvement intervention not linked to improved outcomes after myocardial infarction in India

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients
  • Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.